PrimeVigilance proudly present our latest webinar
‘A Human Touch: Real-World Patient Data in Regulatory Submissions and Beyond’, hosted alongside Pharmafocus and features speakers Dr Forstner, Senior VP and Head of Pharmacoepidemiology and Risk Management and Maartje Smulders, Senior Director Pharmacoepidemiology.
15 February 2019.
PrimeVigilance expert in Benefit-Risk Management, Dr. Michael Forstner PrimeVigilance Senior VP – Head of Risk Management and Pharmacoepidemiology invited to teach at the upcoming DIA Europe Annual Meeting in Vienna, taking place on 4-7 February 2019.
18 January 2019.
PrimeVigilance is pleased to announce that both Dr. Forstner (PrimeVigilance Senior VP – Head of Risk Management and Pharmacoepidemiology) and Dr. Petracek (PrimeVigilance CEO, and former Head of Risk Management at EMA) were selected expert speakers during the upcoming DIA PVRMS conference held January 28-30 in Washington, DC.
13 December 2018.
London, UK – 28 November 2018: Ergomed plc (LSE: ERGO) (‘Ergomed’ or ‘the Company’), a company focused on providing specialised services to the pharmaceutical industry, is delighted to have been shortlisted for the Best Technological Development in Clinical Trials category at the 14th Annual SCRIP Awards
28 November 2018.
Guildford, UK – 24th October 2018
PrimeVigilance have become WORLDWIDE NUMBER ONE in QPPV services with 25 EU QPPV assignments, as well as 25 Deputy EU QPPVs, and our local QPPV/NPRP network covering over 60 countries !
24 October 2018.
We are pleased to share the news that Dr Jan Petracek, PrimeVigilance CEO and a leading expert in Pharmacovigilance, will be lecturing at the upcoming MHRA/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing course held in London on Oct 15 – 19, 2018.
14 September 2018.
+44 (0)1483 307920
(+1) 781 703 5540
United Kingdom (Head Office)